MétaCan
Menu
← Back to cohort
Record W7118317261 · doi:10.1002/alz70856_105873

Glial fibrillary acidic protein is elevated in preclinical AD

2025· article· en· W7118317261 on OpenAlexaboutno aff
Jane E. Joseph, Eric D. Hamlett, Dariusz Pytel, Steven L. Carroll, Katie L Barlis, Federico Rodríguez‐Porcel, Travis E Turner, Andreana Benitez, Olga Brawman‐Mintzer, Andrew B. Lawson, Jens H. Jensen, Jacobo Mintzer

Bibliographic record

VenueAlzheimer s & Dementia · 2025
Typearticle
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsnot available
Fundersnot available
KeywordsGlial fibrillary acidic proteinBiomarkerPositron emission tomographyCognitive declineNeuropsychologyNeurologyAmyloid (mycology)Amyloid beta

Abstract

fetched live from OpenAlex

Abstract Background Non‐specific Alzheimer's Disease (AD) biomarkers like glial fibrillary acidic protein (GFAP) and neurofilament light chain (Nfl) are now included in the diagnosis and staging of AD, but more work is needed to fully understand their utility in early detection of AD. The present study examined plasma GFAP, Nfl, amyloid beta (Aβ) 40, and Aβ42 in individuals with AD, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) who were either amyloid positive (A+) or negative (A‐) according to florbetapir positron emission tomography scan neuroradiological read. The goal was to determine whether individuals with preclinical AD (SCD/A+) show biomarker profiles similar to those expected in AD and MCI (i.e., higher GFAP and Nfl and lower Aβ40 and Aβ42) compared to SCD individuals at lower risk (SCD/A‐). Method Individuals with AD (24 A+, 5 A‐), MCI (21 A+, 17 A‐) and SCD (5 A+, 11 A‐), as determined by clinician referral, completed a blood draw and neuropsychological testing. Blood samples were collected, processed, and stored per previously published guidelines. Plasma samples were assayed using the Neurology 4‐Plex E+ assay on the HD‐X analyzer (Quanterix, MA). Coefficients of variation for all assays were ≤5%. Generalized linear models (GLMs) with false discovery rate correction examined the effects of diagnosis severity (AD, MCI, SCD) and amyloid status (A+, A‐) on plasma levels for each biomarker and the Aβ42/Aβ40 ratio, with covariates of age and sex. Associations between biomarkers and global cognitive functioning, as measured by the Montreal Cognitive Assessment (MoCA), were also examined. Result The Severity x Amyloid status interaction indicated that GFAP was higher (χ 2 (2)=6.9, p = .032) and Aβ42/Aβ40 was lower (χ 2 (2)=13.1, p = .001) in AD/A+ versus AD/A‐ and in SCD/A+ versus SCD/A‐, but amyloid status did not moderate GFAP or Aβ42/Aβ40 in MCI. GLMs for Nfl, Aβ 40, and Aβ 42 did not yield significant effects. GFAP was negatively correlated with MoCA for MCI (ρ=‐.61, p <.001) and SCD (rρ=‐.59, p = .016) groups but not for AD (ρ =‐.15, p = .45). Conclusion Individuals with preclinical AD (SCD/A+) showed biomarker profiles consistent with AD (higher GFAP; lower Aβ42/Aβ40) and GFAP was associated with poorer global cognition in MCI and SCD.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.039
GPT teacher head0.365
Teacher spread0.325 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia→Same topicDementia and Cognitive Impairment Research→French-language works237,207→